Bleeding After Percutaneous Coronary Intervention With Bivalirudin or Unfractionated Heparin and One-Year Mortality
Open Access
- 15 January 2010
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 105 (2), 163-167
- https://doi.org/10.1016/j.amjcard.2009.08.668
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Percutaneous Coronary Intervention Pharmacology: From a Triangle to a SquareJournal of the American College of Cardiology, 2008
- Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions: Appropriateness of Including Bleeding as a Component of a Quadruple End PointJournal of the American College of Cardiology, 2008
- Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes: An Analysis From the ACUITY TrialJournal of the American College of Cardiology, 2007
- Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approachEuropean Heart Journal, 2007
- Bivalirudin for Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2006
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary SyndromesThe American Journal of Cardiology, 2005
- Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventionsThe American Journal of Cardiology, 2003
- Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)European Heart Journal, 2003
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJama-Journal Of The American Medical Association, 2003